ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1523 • 2016 ACR/ARHP Annual Meeting

    The Effect Size of Fibromyalgia on PG-VAS in Rheumatoid Arthritis Patients. Adjustment Proposal in DAS28-ESR

    Luis I Lozano-Plata1, David Vega-Morales2, Ana Arana-Guajardo3, Mario Alberto Garza-Elizondo4, Cassandra Skinner-Taylor4, Roberto Negrete-López1, Jorge Esquivel-Valerio5 and Miguel A Villarreal-Alarcón6, 1Servicio de Reumatología, Departamento de Medicina Interna. Hospital Universitario “Dr. José Eleuterio González”. Universidad Autónoma de Nuevo León, Monterrey, Mexico, 2Universidad Autónoma de Nuevo Léon, Monterrey, Mexico, 3Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 4Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 5Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, 6Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. Jose Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico

    Background/Purpose: The disease activity score (DAS) is a method used to monitor disease activity in Rheumatoid Arthritis (RA). Diseases that cause chronic pain or mood…
  • Abstract Number: 1524 • 2016 ACR/ARHP Annual Meeting

    Suppletion Therapy May be Warranted in RA Patients with Co-Existent Subclinical Hypothyroidism

    Rabia Agca1,2, Hennie Raterman2, Suat Simsek3, Alexandre E. Voskuyl2 and Mike T. Nurmohamed1,4, 1Rheumatology, Amsterdam Rheumatology and immunology Center, Location Reade, Amsterdam, Netherlands, 2Rheumatology, Amsterdam Rheumatology and immunology Center, Location VU University Medical Center, Amsterdam, Netherlands, 3Internal Medicine, Noodwest Ziekenhuisgroep, Location Alkmaar, Alkmaar, Netherlands, 4Rheumatology, Amsterdam Rheumatology and immunology Center, Location VU University Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands

    Background/Purpose: Autoimmune thyroid disease often coexists with RA and has been associated with an elevated cardiovascular (CV) risk, especially in hypothyroid patients. However, the existing…
  • Abstract Number: 1525 • 2016 ACR/ARHP Annual Meeting

    Pain, Physical Function, and Worry (But Not Depression and Poor Sleep) Lead to Greater Fatigue in RA

    Susan J. Bartlett1, Michelle Jones2 and Clifton Bingham III3, 1Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose:  Some view fatigue as resulting from disease activity, while others see it as a natural consequence of the pain, disability, and the emotional burden…
  • Abstract Number: 1526 • 2016 ACR/ARHP Annual Meeting

    Serum  y-Neuropeptide Levels and Its Relationship with Body Fat Mass and Clinical Characteristics in Rheumatoid Arthritis

    Melissa Ramirez-Villafaña1, Paulina Hernandez-Cuervo2, Ana Miriam Saldaña-Cruz3, Edsaul Emilio Perez-Guerrero4,5, Nicte Selene Fajardo-Robledo6, Edy David Rubio-Arellano7, Alejandra Flores-Chavez8, Javier Alejandro Aceves-Aceves9,10, Arnulfo Hernan Nava-Zavala11, Mario Salazar-Paramo12, Miguel Huerta13, Miriam Fabiola Alcaraz-Lopez14, Jorge Ivan Gamez-Nava15 and Laura Gonzalez-Lopez16, 1Departamento Medicina Interna-Reumatología, Instituto Mexicano del Seguro Social, Hospital General Regional 110, Jalisco, Mexico, 2Programa de Doctorado en Ciencias de la Salud Pública, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara. Guadalajara, Jalisco, México., Guadalajara, Mexico, 3Centro Universitario de Investigación Biomédica. Universidad de Colima, Colima, Mexico, 4Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Jalisco, Mexico, 5Doctorado en Farmacología, Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Jalisco, Mexico, 6Laboratorio de Investigación y Desarrollo Farmacéutico, Universidad de Guadalajara, Centro Universitario de Ciencias Exactas e Ingenierias, Jalisco, Mexico, 7Centro Universitario de Investigación Biomédica. Universidad de Colima., Colima, Colima, Mexico, 8Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Jalisco, Mexico, 9Departamento de Medicina Interna-Reumatologia, Hospital General Regional 110, IMSS, Guadalajara, Jalisco, Mexico, 10Posgrado de Farmacología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara., Guadalajara, Jalisco, Mexico, 11Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades Centro Médico Nacional de Occidente, IMSS, Jalisco, Mexico, 12Physiology, HSC, University of Guadalajara, Guadalajara, Mexico, 13Centro Universitario de Investigación Biomédica, Universidad de Colima, Colima, Mexico, 14Departamento Medicina Interna-Reumatología, Instituto Mexicano del Seguro Social, Hospital General Regional 45, Jalisco, Mexico, 15Rheumatology, Centro Medico de Occidente, Guadalajara Jal, Mexico, 16Departamento de Medicina Interna/Rheumatología, Hospital General Regional 110, Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, Mexico

    Background/Purpose: Overweight and obesity are comorbidities that may increase the risk of cardiovascular disease in rheumatoid arthritis. Increase in in body fat is observed in…
  • Abstract Number: 1527 • 2016 ACR/ARHP Annual Meeting

    Anxiety Sensitivity on Indicators of Disease Severity Among Patients with Inflammatory Arthritis

    Renee El-Gabalawy1, Mathew Bernstein2, Cory Mackenzie3, Jitender Sareen4 and Carol Hitchon5, 1Clinical Health Psychology and Anesthesia & Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada, 2Clinical Psychology, University of Manitoba, Winnipeg, MB, Canada, 3Psychology, University of Manitoba, Winnipeg, MB, Canada, 4Psychiatry, University of Manitoba, Winnipeg, MB, Canada, 5University of Manitoba, Winnipeg, MB, Canada

    Background/Purpose:  There has been growing interest in anxiety sensitivity, defined as the fear of behaviors or sensations associated with the experience of anxiety, in chronic…
  • Abstract Number: 1528 • 2016 ACR/ARHP Annual Meeting

    Incretin Axis in Non Diabetic Rheumatoid Arthritis Patients

    Beatriz Tejera1, De Vera-González AM2, Alejandra González Delgado3, Raquel López-Mejías4, Begoña Ubilla4, Fernanda Genre4, Jose M Olmos5, José L Hernández6, Miguel Angel Gonzalez-Gay4 and Ivan Ferraz-Amaro7, 1Rheumatology, Rheumatology Division, Hospital Universitario de Canarias, San Cristobal de La Laguna, Spain, 2Central Laboratory Division, University Hospital of Canary Islands, Tenerife, Spain, 3Central Laboratory Division. Hospital Universitario de Canarias, Tenerife, Spain., Tenerife, Spain, 4Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain, 5Division of Internal Medicine. Hospital Universitario Marqués de Valdecilla, IDIVAL.Universidad de Cantabria. RETICEF, Santander, Spain, 6Division of Internal Medicine. Hospital Universitario Marqués de Valdecilla, IDIVAL. Universidad de Cantabria. RETICEF, Santander, Spain, 7Rheumatology, Rheumatology Division, Hospital Universitario de Canarias, Tenerife, Spain

    Background/Purpose: Cross-sectional study that encompassed 361 non-diabetes individuals; 151 patients with RA and 210 age- and sex-matched controls. IR by homeostatic model assessment (HOMA2), insulin,…
  • Abstract Number: 1529 • 2016 ACR/ARHP Annual Meeting

    Serum Levels of P-Glycoprotein Are Associated with Disease Activity in Rheumatoid Arthritis

    Edsaul Emilio Perez-Guerrero1, Jorge Ivan Gamez-Nava2, Ernesto German Cardona-Muñoz3, Jose Francisco Muñoz-Valle4, Paulina Hernandez-Cuervo1,5, David Bonilla-Lara6,7, Ana Miriam Saldaña-Cruz8, Nicte Selene Fajardo-Robledo9, Silvia Elena Totsuka-Sutto10, Ana Rosa Rincon-Sanchez7, David Cardona-Muller3 and Laura del Carmen Gonzalez-Lopez6, 1Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Jalisco, Mexico, 2Unidad de Investigación Biomédica 02 (Unidad de Investigacion en Epidemiología Clínica), UMAE, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituo Mexicano del Seguro Social, Guadalajara, Mexico, 3Departamento de Fisiología, Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Jalisco, Mexico, 4Instituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Universidad de Guadalajara, Guadalajara, Mexico, 5Programa de Doctorado en Ciencias de la Salud Pública, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara. Guadalajara, Jalisco, México., Guadalajara, Mexico, 6Departamento Medicina Interna-Reumatología, Instituto Mexicano del Seguro Social, Hospital General Regional 110, Jalisco, Mexico, 7Doctorado en Farmacología, Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Jalisco, Mexico, 8Centro Universitario de Investigación Biomédica. Universidad de Colima, Colima, Mexico, 9Laboratorio de Investigación y Desarrollo Farmacéutico, Universidad de Guadalajara, Centro Universitario de Ciencias Exactas e Ingenierias, Jalisco, Mexico, 10Unidad de Investigación Cardiovascular, CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

    Background/Purpose:  Patients with rheumatoid arthritis (RA) exert a wide variety of therapeutic responses to disease controlling anti-rheumatic drugs (DMARDs). P-glycoprotein (P-Gp) is involved in treatment…
  • Abstract Number: 1530 • 2016 ACR/ARHP Annual Meeting

    Temporal Trend of Total Joint Replacement in Rheumatoid Arthritis Patients: A Survival Study

    Luis Rodriguez-Rodriguez1, José Ivorra-Cortes2, Leticia León3, Benjamín Fernández-Gutiérrez1, Lydia Abasolo4 and Isidoro Gonzalez-Alvaro5, 1Department of Rheumatology, Hospital Clinico San Carlos, Madrid, Spain, 2Rheumatology, University Hospital la Fe, Valencia, Spain, 3Rheumatology, Department of Rheumatology, Hospital Clinico San Carlos, Madrid, Spain, 4Rheumatology Department and Heath Research Institute (IdISSC), Hospital Clinico San Carlos, Madrid, Spain, 5Rheumatology, Rheumatology Service, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain

    Background/Purpose : To analyze the temporal trend of incidence rate (IR) of hip and/or knee total joint replacement in a cohort of rheumatoid arthritis (RA)…
  • Abstract Number: 1531 • 2016 ACR/ARHP Annual Meeting

    Decrease in Bone Mineral Density during Three Months of Early RA Measured By DXR Predicts Radiographic Joint Damage after One Year

    Michael Ziegelasch1, Kristina Forslind2, Thomas Skogh3, Katrine Riklund4, Alf Kastbom5 and E. Berglin6, 1Rheumatology/AIR, Linköping, Sweden, 2Department of Medicine, Helsingborgs Lasarett, Section of Rheumatology, Helsingborg, Sweden, 3IKE/Rheumatology, Linköping University, Linköping, Sweden, 4Departments of Diagnostic radiology, Umeå university, Umeå, Sweden, 5Department of Clinical and Experimental Medicine, Rheumatology/AIR, Linköping, Sweden, 6Department of Publiic Health and Clinical Medicin/Rheumatology, Umeå university, Umea, Sweden

    Background/Purpose:   Digital X-ray radiogrammetry (DXR) is a method to calculate peripheral bone mineral density (BMD) which calculates BMD of the hands (DXR-BMD). The aim…
  • Abstract Number: 1532 • 2016 ACR/ARHP Annual Meeting

    Sleep Hygiene Practices and Associations with Patient-Reported Outcomes in Rheumatoid Arthritis

    Sapna Sangani1 and Joshua F. Baker1,2, 1Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Medicine/Rheumatology, University of Pennsylvania and Philadelphia VAMC, Philadelphia, PA

    Background/Purpose: Previous studies showed a high prevalence of sleep disturbances in Rheumatoid Arthritis (RA). Poor sleep has been associated with patient-reported outcomes (PROs) for measuring…
  • Abstract Number: 1533 • 2016 ACR/ARHP Annual Meeting

    Pregnancy Outcomes in Women with Rheumatoid Arthritis : A Systematic Review and Meta-Analyses

    Anne-Lise Gaillard1, Thomas Barnetche2 and Thierry Schaeverbeke3, 1Rhumatologie, CHU Bordeaux Pellegrin, Bordeaux, France, 2Rheumatology Department, Pellegrin University Hospital, BORDEAUX, France, 3Rheumatology Department, Bordeaux Hospital, Bordeaux, France

    Background/Purpose: Actually better control of rheumatoid arthritis (RA) activity leads to new interrogations and daily questions about pregnancy. Only few studies have studied pregnancy outcomes…
  • Abstract Number: 1534 • 2016 ACR/ARHP Annual Meeting

    Assessment of the Relationship of the Static and Dynamic Balance Parameters with Clinical, Functional and Radiological Findings in Patients with Rheumatoid Arthritis

    Canan Sanal Top1, M Tuncay Duruoz2 and Osman Hakan Gunduz3, 1PMR Department, Marmara University School of Medicine, Istanbul, Turkey, 2PMR Department, Rheumatology Division, Marmara University School of Medicine, Sisli-Istanbul, Turkey, 3Physical Medicine and Rehabilitation, Marmara University School of Medicine, Istanbul, Turkey

    Background/Purpose:  Lower extremity arthritis, proprioceptive dysfunction related to foot deformities, muscle weakness, joint restrictions, biomechanical disoerders, fatigue, sleep disorders, depression, and pain are frequently seen…
  • Abstract Number: 1535 • 2016 ACR/ARHP Annual Meeting

    Depression in Rheumatoid Arthritis

    Christian Ferro1, Carlos Ríos2, Mario Moreno Alvarez3, Maria Jose Intriago4, Génessis Maldonado4, Claudia Aguirre4, Carlos Paredes4, Jenny Cardenas4, Nelson Cordova5, Rafael López5 and Jose Martinez5, 1Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador, 2Centro de Reumatología y Rehabilitación CERER, Guayaquil, Ecuador, 3Rheumatology, Hospital Luis Vernaza, Rheumatology Service, Guayaquil, Ecuador, 4Universidad Espíritu Santo, Guayaquil, Ecuador, 5Hospital Luis Vernaza, Guayaquil, Ecuador

    Background/Purpose: Depression is an important comorbidity in patients with rheumatoid arthritis (RA). Its incidence is variable (10-25%), being more frequent in women1. Wolfe et al.…
  • Abstract Number: 1536 • 2016 ACR/ARHP Annual Meeting

    Sleep Disturbance in Patients with Rheumatoid Arthritis – a Cross-Section Study

    Lingshu Zhang1, Yuan Xu2, Yi Liu3 and Cong-Qiu Chu4, 1Department of Rheumatology, West China Hospital, Sichuan University, Chengdu, China, 2The First Affiliated Hospital of Southwest Medical University, Suzhou, China, 3Department of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu, China, 4Rheumatology, Oregon Health & Science University, Portland, OR

    Background/Purpose: Sleep disturbance is common in patients with rheumatoid arthritis (RA). Poor sleep can result in increased psychological distress, depression, fatigue, inability to work, socioeconomic…
  • Abstract Number: 1537 • 2016 ACR/ARHP Annual Meeting

    Prevalence and Impact of Inflammatory Multimorbid Conditions on Trajectories of Disease Activity in the First Year of Follow-up in a Multi-Center Era Cohort

    Orit Schieir1, Susan J. Bartlett2, Carol Hitchon3, Janet E. Pope4, Gilles Boire5, Boulos Haraoui6, Edward C. Keystone7, Carter Thorne8, Diane Tin9 and Vivian P. Bykerk10, 1McGill University, Montreal, ON, Canada, 2Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, 3University of Manitoba, Winnipeg, MB, Canada, 4University of Western Ontario, St Joseph's Health Care, London, ON, Canada, 5Rheumatology Division, CHUS - Sherbrooke University, Sherbrooke, QC, Canada, 6Institut de Rhumatologie de Montréal, Montreal, QC, Canada, 7Mount Sinai Hospital, Toronto, ON, Canada, 8University of Toronto and Southlake Regional Health Centre, Newmarket, ON, Canada, 9The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 10Divison of Rheumatology, Hospital for Special Surgery, New York, NY

    Background/Purpose: Patients with rheumatoid arthritis also commonly report other chronic conditions (“multimorbidity”) with higher counts of conditions associated with reduced response to treatment and persistent…
  • « Previous Page
  • 1
  • …
  • 1517
  • 1518
  • 1519
  • 1520
  • 1521
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology